In China, a significant number of patients are plagued by rheumatic and autoimmune diseases. Early diagnosis and standardized treatment are crucial to enable patients to return to their normal lives as soon as possible. To promote clinical and basic research in the field of rheumatology and autoimmune diseases, enhance the level of diagnosis and treatment of rheumatic and autoimmune diseases, improve the diagnostic and treatment capabilities of rheumatologists, and facilitate exchanges and cooperation between rheumatology and other multidisciplinary fields, the Chengdu High-tech Medical Association successfully held a series of online conferences on rheumatology and autoimmune diseases, as well as a series of Sichuan-Guizhou rheumatology clinical practice exchange conferences, spanning three phases from October 28 to December 17, 2025. The conference invited renowned experts in the field of rheumatology and autoimmune diseases to deliver special academic reports, conduct academic discussions and exchanges centered around classic cases and cutting-edge technologies in rheumatology and autoimmune diseases, and share with colleagues the latest concepts, advancements, and information in the current clinical rheumatology and autoimmune diseases field. Participants expressed that they had benefited greatly from the conference.